LXRepair est membre de Lyonbiopôle

General information

7 parvis Louis Néel

38040 Grenoble

Incorporated in: 2013/09/23

Number of employees: 6

More information


Main activity

LXRepair develops multiplexed high value functional tests to characterize DNA Repair Enzyme Activities. The objective of LXRepair is to design Companion Diagnostic kits with original DNA Repair biomarkers to help clinicians to optimize radiotherapy or chemotherapy to fight cancer. LXRepair proposes research tools for academic and industrial researchers allowing to identify DNA Repair based biomarkers in Pharma Drug Development, Cosmetic-Aging Sciences and Environmental and Industrial Toxicology. LXRepair has a R&D Lab offering customized services on pre-clinical models (human and non-human).


Looking for funding: Yes

Private funding obtained: LXRepair raised €1.1M from KREAXI, CEA-Investment, XPAND INVESTMENT Ltd of the KIS Group, Grenoble Angels, Savoie Mont-Blanc Angels, Gentiane Participation and individual investors

Public funding obtained: LXRepair is supported by Bpi France (2013 i-lab contest and 2017 Innovation program).

Products / Services / Technologies
Partnership opportunities / Licensing

Strategic area of application
Medical Technologies

Application market
Dermatology & Cosmetology - Neurological diseases - Oncology

Diagnostics - CRO

Analytical & Diagnostic services - Genomics & Proteomics, Biochips - Screening services